NCT00117442View on ClinicalTrials.gov

A Study of Carboplatin/Paclitaxel With Pegfilgrastim Supported by Haematopoietic Progenitor Cell Re-Infusion in Whole Blood

PHASE2CompletedINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

August 31, 2002

Primary Completion Date

August 31, 2004

Study Completion Date

December 31, 2004

Conditions
Breast CancerLung CancerOvarian Cancer
Interventions
DRUG

carboplatin

Chemotherapy

DRUG

paclitaxel

chemotherapy

DRUG

pegfilgrastim

Growth factor for mobilization

Sponsors

Lead Sponsor

Amgen
All Listed Sponsors
lead

Amgen

INDUSTRY